Jetta Kelppe1, Hanna Thorén2,3, Caj Haglund4,5, Timo Sorsa6,7, Jaana Hagström1,5,8. 1. Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB, Helsinki, Finland. 2. Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Turku, Finland. 3. Department of Oral and Maxillofacial Diseases, Turku University Hospital, Turku, Finland. 4. Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 5. Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, Finland. 6. Department of Oral and Maxillofacial Diseases, Head and Neck Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 7. Department of Dental Medicine, Karolinska Institute, Huddinge, Sweden. 8. Department of Oral Pathology and Radiology, University of Turku, Turku, Finland.
Abstract
OBJECTIVES: Ameloblastoma is a benign, locally aggressive odontogenic tumor with high recurrence rates. Matrix metalloproteinases (MMPs) mediate extracellular integrity in normal and pathological conditions, and exert multiple functions coordinating inflammation and tumor progression. E-cadherin and beta-catenin are adherence junction molecules in cell-to-cell connections. We investigated the involvement of MMP-7, -8, -9, E-cadherin, and beta-catenin in ameloblastoma and the surrounding extracellular matrix. MATERIAL AND METHODS: Our material consisted of 30-34 tissue samples from ameloblastoma patients of Helsinki University Hospital. We used immunohistochemistry to detect the expression of the biomarkers. Two oral pathologists independently scored the immunoexpression intensities and statistical calculations were made based on the results. RESULTS: E-cadherin expression was weaker in the maxillary than in mandibular ameloblastomas. Beta-catenin was expressed in the ameloblastoma cell membranes. We detected MMP-8 and -9 expression in polymorphonuclear neutrophils in the extracellular area and these MMPs correlated positively with each other. Osteoclasts lining bone margins and multinuclear giant cells expressed MMP-9. Neither MMP-8 nor MMP-9 immunoexpression could be detected in ameloblastoma cells. MMP-7 expression was seen in some apoptotic cells. CONCLUSION: The fact that E-cadherin immunoexpression was weaker in maxillary compared to mandibular ameloblastomas might associate to earlier recurrences. It promotes the idea of mandibular and maxillary ameloblastoma exerting differences in their biologies. We detected MMP-8 and -9 in polymorphonuclear neutrophils which relates to these MMPs participating in extracellular remodeling through a mild inflammatory process. Bone degradation around ameloblastoma may be due to MMP-9 in osteoclasts but this phenomenon might be an independent process and needs further investigations.
OBJECTIVES: Ameloblastoma is a benign, locally aggressive odontogenic tumor with high recurrence rates. Matrix metalloproteinases (MMPs) mediate extracellular integrity in normal and pathological conditions, and exert multiple functions coordinating inflammation and tumor progression. E-cadherin and beta-catenin are adherence junction molecules in cell-to-cell connections. We investigated the involvement of MMP-7, -8, -9, E-cadherin, and beta-catenin in ameloblastoma and the surrounding extracellular matrix. MATERIAL AND METHODS: Our material consisted of 30-34 tissue samples from ameloblastoma patients of Helsinki University Hospital. We used immunohistochemistry to detect the expression of the biomarkers. Two oral pathologists independently scored the immunoexpression intensities and statistical calculations were made based on the results. RESULTS: E-cadherin expression was weaker in the maxillary than in mandibular ameloblastomas. Beta-catenin was expressed in the ameloblastoma cell membranes. We detected MMP-8 and -9 expression in polymorphonuclear neutrophils in the extracellular area and these MMPs correlated positively with each other. Osteoclasts lining bone margins and multinuclear giant cells expressed MMP-9. Neither MMP-8 nor MMP-9 immunoexpression could be detected in ameloblastoma cells. MMP-7 expression was seen in some apoptotic cells. CONCLUSION: The fact that E-cadherin immunoexpression was weaker in maxillary compared to mandibular ameloblastomas might associate to earlier recurrences. It promotes the idea of mandibular and maxillary ameloblastoma exerting differences in their biologies. We detected MMP-8 and -9 in polymorphonuclear neutrophils which relates to these MMPs participating in extracellular remodeling through a mild inflammatory process. Bone degradation around ameloblastoma may be due to MMP-9 in osteoclasts but this phenomenon might be an independent process and needs further investigations.
Authors: I Nishizuka; Y Ichikawa; T Ishikawa; M Kamiyama; S Hasegawa; N Momiyama; K Miyazaki; H Shimada Journal: Cancer Lett Date: 2001-11-28 Impact factor: 8.679
Authors: B F Ribeiro; D P P Iglesias; G J F Nascimento; H C Galvão; A M C Medeiros; R A Freitas Journal: Oral Dis Date: 2009-06-10 Impact factor: 3.511
Authors: Thomas L Andersen; Maria del Carmen Ovejero; Tove Kirkegaard; Thomas Lenhard; Niels T Foged; Jean-Marie Delaissé Journal: Bone Date: 2004-11 Impact factor: 4.398
Authors: Cristina Blanco-Vázquez; Marta Alonso-Hearn; Natalia Iglesias; Patricia Vázquez; Ramón A Juste; Joseba M Garrido; Ana Balseiro; María Canive; Javier Amado; Manuel A Queipo; Tania Iglesias; Rosa Casais Journal: Front Vet Sci Date: 2022-03-10